COCRYSTAL PHARMA, INC. Amortization of Debt Discount (Premium)
COCRYSTAL PHARMA, INC. (COCP) reported Amortization of Debt Discount (Premium) of $2.00 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2014-03-31
- COCRYSTAL PHARMA, INC. amortization of debt discount (premium) for the quarter ending 2012-12-31 was $0.00.
- COCRYSTAL PHARMA, INC. amortization of debt discount (premium) for the quarter ending 2012-09-30 was $0.00.
- COCRYSTAL PHARMA, INC. amortization of debt discount (premium) for fiscal 2013 was $2.00M, a 27.41% decline from fiscal 2012.
- COCRYSTAL PHARMA, INC. amortization of debt discount (premium) for fiscal 2012 was $2.76M.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2013-12-31 | $2.00M 10-K · filed 2014-03-31 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $0.00 derived: sum of 2 quarters · filed 2014-03-31 | $2.76M 10-K · filed 2014-03-31 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $2.76M 10-Q · filed 2012-11-14 | ||
| 2012-06-30 | $2.76M 10-Q/A · filed 2012-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |